SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
Authors:
- Eric LetouzéELEric Letouzé
- Cosimo MartinelliCMCosimo Martinelli
- Céline LoriotCLCéline Loriot
- Nelly BurnichonNBNelly Burnichon
- Nasséra AbermilNANasséra Abermil
- Chris OttolenghiCOChris Ottolenghi
- Maxime JaninMJMaxime Janin
- Mélanie MenaraMMMélanie Menara
- An Thach NguyenANAn Thach Nguyen
- Paule BenitPBPaule Benit
- Alexandre BuffetABAlexandre Buffet
- Charles MarcaillouCMCharles Marcaillou
Top Cited Papers
- 1 June 2013
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 23 (6) , 739-752
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor CellsCancer Cell, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutationsProceedings of the National Academy of Sciences, 2010
- Succinate dehydrogenase – Assembly, regulation and role in human diseaseMitochondrion, 2010
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- The Epigenomics of CancerCell, 2007
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- Comprehensive analysis of CpG islands in human chromosomes 21 and 22Proceedings of the National Academy of Sciences, 2002